Kura Oncology(KURA)
SAN DIEGO, CABiotechnology
Focus: Kura Oncology is a San Diego-based public biotech focused on small-molecule oncology therapeutics, currently in clinical-stage development with no approved products generating revenue.
Profile data last refreshed 41m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
7-2 this month
Stable — net -2 jobs in 30d
4 added, 6 removed. Backfill posture.
Should You Work at Kura Oncology?
AI assessmentKura is a promising early-stage oncology biotech with a focused pipeline and potential Phase 3 catalysts, but pre-revenue status and cash burn present execution and stability risks.
Why Work Here
- Lead scientist/clinical roles on Phase 3 Ziftomenib program in AML with near-term catalysts and commercial upside
- Extensive pipeline with 20+ active trials across multiple oncology indications provides diverse project exposure
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT04809233Expanded Access to Tipifarnib
N/AHelp build intelligence for Kura Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.